All About Multiple Sclerosis

More MS news articles for April 2004

Research advances in MS reported at American Academy of Neurology meeting

April 30, 2004
The National Multiple Sclerosis Society

Neurologists and neuroscientists from around the world gathered to share their research findings at the American Academy of Neurology’s 56th Annual Meeting in San Francisco April 24 to May 1, 2004. Following are selected highlights from over 200 presentations that had relevance to multiple sclerosis.

During the meeting, the 2004 John Dystel Prize for Multiple Sclerosis Research was awarded to Professor Lawrence Steinman of Stanford University, an innovative neuroimmunologist who has contributed much to our understanding of MS, and who has translated his findings to develop therapeutic strategies that are already under study in people with MS. Details about Dr. Steinman’s outstanding contributions are available here.

Clinical Trials

  • Results from a study of the oral immune-modulating drug laquinimod were presented by Dr. Magnhild Sandberg-Wollheim (Lund, Sweden) on behalf of colleagues in Amsterdam and Sweden. The placebo-controlled, early phase trial of two doses of the agent was conducted in 209 persons with relapsing forms of MS. The drug was well tolerated, and those on the higher dose had significantly fewer new active MS brain lesions during the 24 weeks of testing. Larger studies are needed to further explore the drug’s potential to help those with relapsing MS.
  • Studies in Primary-Progressive MS Memory Help? Long-Term Extensions of Clinical Trials Early Clinical Studies Treatment of Optic Neuritis On the Horizon These and many other studies presented at this meeting testify to the growing breadth and pace of research into multiple sclerosis. Followup to these studies will help shape efforts to find new and better treatments and hopefully, a way to restore function in those with MS.

    Copyright © 2004, The National Multiple Sclerosis Society